Sciwind Biosciences
VerifiedA drug research and development company for metabolic diseases.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$280—420m (Dealroom.co estimates Oct 2021.)
Hangzhou Zhejiang (HQ)
No columns specified